Table 4. Summary of mortality rates.
| Patients, n (%) | ||
|---|---|---|
|
|
||
| Deaths by 30-day increments from start of treatment, n (%) | Barasertib 1200 mg (n=48) | LDAC 400 mg (n=26) |
| 30 | 6 (13) | 4 (15) |
| 60 | 9 (19) | 7 (27) |
| 90 | 13 (27) | 10 (39) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.